Self-reported reactogenicity of CoronaVac (Sinovac) compared with Comirnaty (Pfizer-BioNTech): A prospective cohort study with intensive monitoring
Francisco Tsz Tsun Lai, Miriam T Y Leung, Edward W. Chan, Lei Huang, Lauren Ka Wun Lau, Kuan Peng, Janice Ching Nam Leung, Min Fan, Kailin Chen, Dawn Hei Lum, Xue Li, Celine Sze Ling Chui, Eric Yuk Fai Wan, Carlos King Ho Wong, Edwin Fung Shing Lam, Terence Yung Yan Cheung, Benjamin J. Cowling, Ian Chi Kei Wong, Esther W. Chan
Topics & Concepts
ReactogenicityMedicineOdds ratioAdverse effectProspective cohort studyConfidence intervalCohort studyCohortPediatricsInternal medicineImmunologyImmune systemImmunogenicitySARS-CoV-2 and COVID-19 ResearchLong-Term Effects of COVID-19Retinal and Optic Conditions